Ensign Peak Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Ensign Peak Advisors's RGEN Position: Q2 2026 in Review
Ensign Peak Advisors reduced its Repligen (RGEN) stake by 8.3% in Q2 2026, selling an estimated $778K and leaving 69,687 shares worth $9.51M. The position accounts for 0.02% of the portfolio, ranked #446.
Ensign Peak Advisors first reported a position in RGEN in Q4 2019 and has held it in 27 quarters since. The position peaked at $20.7M in Q3 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Ensign Peak Advisors held 69,687 shares of Repligen worth $9.51M as of Q2 2026.
- Ensign Peak Advisors sold 6,333 Repligen shares in Q2 2026, an estimated $778K.
- Repligen made up 0.02% of Ensign Peak Advisors's portfolio in Q2 2026, its #446 holding.
- Ensign Peak Advisors first reported a position in Repligen in Q4 2019 and has held it in 27 quarters since.
- Ensign Peak Advisors's Repligen position peaked at $20.7M in Q3 2024.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.